ReviewJournal of cancer research and clinical oncology2022

Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective.

Yu-Chi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.